sábado, 17 de enero de 2015

AHRQ Patient Safety Network: Tragic error with neuromuscular blocker should prompt risk assessment by all hospitals.

AHRQ Patient Safety Network

AHRQ Patient Safety Network

Tragic error with neuromuscular blocker should prompt risk assessment by all hospitals.

ISMP Medication Safety Alert! Acute Care Edition. December 18, 2014;19:1,4.

This newsletter article discusses an adverse drug event involving a patient who died after receiving a neuromuscular blocker instead of a seizure control agent. The preparation error was associated withincorrect labeling. Because neuromuscular blocking agents are considered high-alert medications, more robust administration processes should be employed to reduce the potential for mix-ups.

Free full text icon indicating hyperlink to external website
Related news article icon indicating hyperlink to external website




Related Resources
COMMENTARY
Weighing in on medication safety.
Paparella S. J Emerg Nurs. 2009;35:553-555.
NEWSPAPER/MAGAZINE ARTICLE
A hospital races to learn lessons of Ferrari pit stop.
Naik G. Wall Street Journal. November 14, 2006:A1. [reprinted on Post-gazette.com].
STUDY
Medication errors among acutely ill and injured children treated in rural emergency departments.
Marcin JP, Dharmar M, Cho M, et al. Ann Emerg Med. 2007;50:361-367.e1-2.
BOOK/REPORT
Fluorouracil Incident Root Cause Analysis Report.
Toronto, ON, Canada: Institute for Safe Medication Practices Canada. May 8, 2007.
View all related resources...


No hay comentarios: